Issue 149

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

Here's what's going on in FDA-regulated and pharma-focused digital

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases

Research Reports

All Research Reports
The Noom Report
10.29.21
39 min. read
The Crossover Health Report
4.19.21
22 min. read
Analysis: Livongo founders’ HAAC SPAC
1.25.21
11 min. read
The UnitedHealth Group Report
12.30.20
30 min. read

Newsletters

All Newsletters
More Akili, Pear HCPCS. Clinical trial updates
5.13.22
8 min. read
13 secret health tech investments
5.09.22
4 min. read
Biogen-MedRhythms. Pear and Better salaries. Trials
5.06.22
7 min. read
Vida coaches FBI. Accolade loses Comcast. Vanguard stack
5.04.22
5 min. read

Databases

All Databases
Big Employers’ Digital Health Benefits Stacks
3.02.22
< 1 min. read
What Public Digital Health Companies Pay Their Execs
2.18.22
< 1 min. read